Market Cap | ₹4,882Cr |
ROE | 3.16% |
P/E Ratio(TTM) | 164.41 |
EPS(TTM) | 1.18 |
P/B Ratio | 6.93 |
Dividend Yield | 0.00% |
Industry P/E | 34.97 |
Book Value | 28.00 |
Debt to Equity | 0.68 |
Face Value | 2 |
Parent Organisation | Sequent Scientific |
Managing Director | Mr. Rajaram Narayanan |
NSE Symbol | SEQUENT |
FUND NAME | AUM(%) |
---|---|
Quant Small Cap Fund Direct Plan Growth | 1.33% |
UTI Healthcare Fund Direct Growth | 1.32% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 103.04 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.17 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.78 | ||
Wockhardt | NA (0.00%) | -194.72 |